Prefilled Syringe Specific Testing Service for Drug Product Release

Methods Regulatory Capabilities Contact Us FAQ

Prefilled syringe specific testing is a dedicated service for the drug product release of prefilled syringes. It systematically quantifies silicone oil residual, tip cap seal integrity, and piston glide force, with methods designed to align with USP, ISO, and GMP requirements to ensure dosing accuracy, sterility assurance, and user experience.

Prefilled syringes are a primary packaging form for biologics, vaccines, and small‑volume injectables. They consist of a barrel, a piston, a plunger rod, a tip cap, and a needle (if integrated). Multiple components and interfaces increase leakage risk. Excessive silicone oil can migrate into the drug product, forming visible particles. Insufficient silicone oil causes abnormal glide force, affecting clinical administration. Tip cap integrity directly impacts container closure integrity (CCI) and sterility.

Creative Biogene provides one‑stop services from release testing to IND/BLA submission data packages. Methods are aligned with USP <382>/<1382>, ISO 11040, ISO 11608, and YY/T 0962.

Technical Principles & Methods

Silicone Oil Residual Testing

Silicone oil (PDMS) lubricates the barrel to ensure smooth piston movement. Two core risks: migration into drug product forming visible particles (misinterpreted as protein aggregates), and insufficient oil causing abnormal glide force (leading to dosing failure). Accurate control is critical.

Solvent extraction gravimetry – Extract silicone oil with ethyl acetate, evaporate solvent, weigh residue. High accuracy, suitable for routine release.
ATR‑FTIR – Detects Si–CH₃ absorbance at 1260 cm⁻¹; fast, minimal solvent, high selectivity.

Tip Cap Integrity Testing

The seal between the tip cap and the barrel is critical for sterility. Leak risks exist at the piston‑barrel interface, needle hub, and plunger connection. USP <382> recommends deterministic methods over probabilistic methods.

Vacuum decay – Place the syringe in a test chamber, apply vacuum. Pressure change indicates leakage. Non‑destructive, sensitivity 1‑5 μm, widely applicable.
High voltage leak detection (HVLD) – Apply high voltage across the syringe; current change at the leak point due to conductive drug product. Suitable for suspensions, high viscosity products, and biologics. Locates the leak site.
Pressure decay – Monitor pressure drop over time. Complementary method.

Method selection

Dosage Form	Recommended Method	Reason
Low viscosity solutions	Vacuum decay	High accuracy, non‑destructive
Suspensions/emulsions/proteins	HVLD	Detects high viscosity and opaque products
Lyophilized powders	Vacuum decay (optimized)	Product non‑conductive
Stability studies	Vacuum decay	Non‑destructive

Glide Force Testing

Two parameters: break loose force (maximum force to initiate piston movement) and glide force (average force to sustain movement). Both must be within limits to ensure safe and consistent dosing.

Regulatory Basis

Document	Key Requirement
USP <382>	Effective Dec 1, 2025; replaces USP <381> elastomeric function; requires functional assessment of assembled system (break loose, glide, seal integrity).
USP <1382>	Supplementary guidance for elastomeric closure functionality.
ISO 11040‑4:2024	Glass barrel materials, dimensions, quality, and performance.
ISO/FDIS 11040‑8:2026‑03	Draft for finished prefilled syringe quality and functional performance.
ISO 11608	Needle‑based injection systems (including auto injectors).
ASTM F2338	Vacuum decay package seal integrity.
21 CFR 211	Finished pharmaceutical GMP.

Capabilities

PFS type-specific protocols – Glass (borosilicate) or plastic (COP/COC) barrels; auto injector combination testing.
Silicone oil method development and validation – For novel coatings or formulations.
CCI method development and validation – For special dosage forms (suspensions, high viscosity biologics); sensitivity validation and positive control preparation.
Correlation analysis – Between glide force and silicone oil residual to support coating process optimization.
Stability study support – Multi‑timepoint trends (0, 3, 6, 9, 12, 24, 36 months).
Auto injector combined testing – For complete system functional performance.

Contact Us

For a customized testing strategy, USP <382> compliance assessment, or IND/BLA submission support for your prefilled syringe product, contact Creative Biogene's technical team.

FAQ

Q1: How to choose between vacuum decay and HVLD?

A: Choose based on dosage form and product properties. Vacuum decay is suitable for low viscosity solutions (aqueous, small molecules) – CDE recommended, sensitivity 1‑5 μm, non‑destructive, ideal for stability studies. HVLD is suitable for suspensions, emulsions, high viscosity products, and proteins – can locate leaks, but post‑test biological activity should be assessed. Creative Biogene recommends the optimal method based on product characteristics.

* For research use only. Not intended for any clinical use.

Quick Inquiry